SCHEMBL19853771

SCHEMBL19853771

C[C@@H](O)[C@@H](C(N)=O)N1CC2(CCN(OCc3ccccc3)CC2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
ADAM17 P78536 1/20 0.37
ALDH1A1 P00352 2/20 0.36
RIPK1 Q13546 1/20 0.36
CYP2D6 P10635 1/20 0.36
TACR1 P25103 2/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
DPP4 P27487 1/20 0.33
KCNH2 Q12809 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
DHFR P00374 4/20 0.33
OPRM1 P35372 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
LIPE Q05469 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21034523 0.85 OPRM1 (0.42) GRIN2BGRIN2CMMP2MMP9ADAM17
SCHEMBL19853726 0.85 OPRM1 (0.42) GRIN2BGRIN2CMMP2MMP9ADAM17
SCHEMBL19853697 0.82 RIPK1 (0.37) MMP2MMP9ADAM17ALDH1A1RIPK1
SCHEMBL30801716 0.80 CCR1 (0.51) CYP2D6CYP2C19DPP4KCNH2DPP7
SCHEMBL19853693 0.76 RIPK1 (0.48) ALDH1A1RIPK1CYP2D6CYP2C19SMN1; SMN2
SCHEMBL23467759 0.74 GRIN2B (0.36) GRIN2BGRIN2CALDH1A1RIPK1CYP2D6
SCHEMBL19629074 0.74 GRIN2B (0.51) GRIN2BGRIN2C
SCHEMBL30801671 0.74 CCR1 (0.45) ALDH1A1DPP4KCNH2DPP7
SCHEMBL22087702 0.74 GRIN2B (0.41) GRIN2BGRIN2CALDH1A1RIPK1CYP2D6
SCHEMBL19853347 0.74 GRIN2B (0.41) GRIN2BGRIN2CALDH1A1RIPK1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026763-A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF APTINYX INC. (US) 2018-02-08 WO disclosed